DE69712878T2 - Phosphatasemodulator - Google Patents

Phosphatasemodulator

Info

Publication number
DE69712878T2
DE69712878T2 DE69712878T DE69712878T DE69712878T2 DE 69712878 T2 DE69712878 T2 DE 69712878T2 DE 69712878 T DE69712878 T DE 69712878T DE 69712878 T DE69712878 T DE 69712878T DE 69712878 T2 DE69712878 T2 DE 69712878T2
Authority
DE
Germany
Prior art keywords
pct
erf1
interaction
sec
pp2a
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69712878T
Other languages
English (en)
Other versions
DE69712878D1 (en
Inventor
Arthur Hemmings
Prof Goris
Dr Zolnierowicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Erfindungen Verwaltungs GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606707.9A external-priority patent/GB9606707D0/en
Priority claimed from GBGB9626470.0A external-priority patent/GB9626470D0/en
Application filed by Novartis Erfindungen Verwaltungs GmbH, Novartis AG filed Critical Novartis Erfindungen Verwaltungs GmbH
Publication of DE69712878D1 publication Critical patent/DE69712878D1/de
Application granted granted Critical
Publication of DE69712878T2 publication Critical patent/DE69712878T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69712878T 1996-03-29 1997-03-17 Phosphatasemodulator Expired - Fee Related DE69712878T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606707.9A GB9606707D0 (en) 1996-03-29 1996-03-29 Phospatase modulator
GBGB9626470.0A GB9626470D0 (en) 1996-12-20 1996-12-20 The catalytic subunit of protein phosphatase 2A associates with the translation termination factor eRF1
PCT/EP1997/001330 WO1997037037A1 (en) 1996-03-29 1997-03-17 Phosphatase modulator

Publications (2)

Publication Number Publication Date
DE69712878D1 DE69712878D1 (en) 2002-07-04
DE69712878T2 true DE69712878T2 (de) 2002-11-07

Family

ID=26309022

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69712878T Expired - Fee Related DE69712878T2 (de) 1996-03-29 1997-03-17 Phosphatasemodulator

Country Status (7)

Country Link
US (1) US6159704A (de)
EP (1) EP0889971B1 (de)
JP (1) JP4033490B2 (de)
AT (1) ATE218165T1 (de)
AU (1) AU2027997A (de)
DE (1) DE69712878T2 (de)
WO (1) WO1997037037A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602713B1 (en) 2001-02-09 2003-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of protein phosphatase 2 catalytic subunit beta expression
US6465250B1 (en) 2001-02-09 2002-10-15 Isis Pharmaceuticals, Inc. Antisense modulation of protein phosphatase 2 catalytic subunit alpha expression
US6093544A (en) 1997-05-20 2000-07-25 Cornell Research Foundation, Inc. Rupestris stem pitting associated virus nucleic acids, proteins, and their uses
US6656696B2 (en) * 1999-02-26 2003-12-02 Cyclacel Compositions and methods for monitoring the phosphorylation of natural binding partners
US6828106B2 (en) * 1999-02-26 2004-12-07 Cyclacel Limited Methods and compositions using coiled binding partners
US6972182B1 (en) * 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using coiled binding partners
EP1196773A1 (de) * 1999-07-12 2002-04-17 McGILL UNIVERSITY E4orf4 und ppa2 polypeptide, modulatoren und mimetika zur selektiven induzierung von zelltod
FR2827866B1 (fr) * 2001-07-27 2004-12-10 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
AU2003220222A1 (en) * 2002-03-13 2003-09-29 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP1843734A4 (de) 2005-02-03 2008-09-10 Signum Biosciences Inc Zusammensetzungen und verfahren zur intensivierung kognitiver funktionen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180665A (en) * 1990-11-21 1993-01-19 Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada Method for quantitatively assaying the presence of diarrhetic shellfish poisoning toxins in marine samples
EP0551200A1 (de) * 1992-01-07 1993-07-14 National University Of Singapore Protein-Phosphatase-Inhibitoren zur Verwendung in der Therapie
ATE398287T1 (de) * 1996-03-30 2008-07-15 Medical Res Council Wechselwirkungen der katalytischen untereinheit der proteinphosphatase 1
WO1998014606A1 (en) * 1996-10-04 1998-04-09 South Alabama Medical Science Foundation Method for diminishing myocardial infarction using protein phosphatase inhibitors
GB9625179D0 (en) * 1996-12-04 1997-01-22 Ver Nl Kanker Inst Phosphatase subunit polypeptide

Also Published As

Publication number Publication date
DE69712878D1 (en) 2002-07-04
US6159704A (en) 2000-12-12
EP0889971A1 (de) 1999-01-13
JP4033490B2 (ja) 2008-01-16
EP0889971B1 (de) 2002-05-29
ATE218165T1 (de) 2002-06-15
JP2000514642A (ja) 2000-11-07
AU2027997A (en) 1997-10-22
WO1997037037A1 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
DE69831777D1 (de) Framework zur finanziellen Integration von Geschäftsapplikationen
MXPA02001228A (es) Sistema y metodo para determinar requerimientos especificos de documentos de requerimientos generales.
DE69825856D1 (de) System zur Analyse von Tabellenbildern
DE69839456D1 (de) System zur Inspektion, Bewertung und Verwaltung von Ausrüstungen
DE59814072D1 (de) Verwendung von Agonisten des zentralen Cannabinoid-Rezeptors CB1
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
NO20004526D0 (no) Modulatorer for proteintyrosinfosfataser
IS4955A (is) Tálmar gegn frumusamloðun
HU9603328D0 (en) Retroviral protease inhibitor combinations
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ES2172657T3 (es) Inhibidores de trombina.
DE69942909D1 (de) Laserkammer zur zerstreuung von druckwellen
DE69712878T2 (de) Phosphatasemodulator
ATE218954T1 (de) Holzschutzmittel für den nachschutz
DE69626042T2 (de) Verfahren zur anwendung einer beschallungsanlage für grosse räume und eine beschallungsanlage
ES2191830T3 (es) Inhibidores de trombina.
ATE252158T1 (de) Nicht-nukleotid verknüpfende reagentien
DE69618221T2 (de) Mechanismus zur wartung objektorientierter "methoden" der keine unterbrechung des computersystems erfordert
TR199900310T2 (xx) Trombin inhibit�rleri
WO1999019513A3 (en) Methods for detecting compounds which modulate the activity of an lpa receptor
DE59600580D1 (de) Verfahren zur lastmessung
PL329743A1 (en) Method of separating racemic ketanine
AU2001228488A1 (en) Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels
ATE228760T1 (de) Thrombininhibitoren
DE69635771D1 (de) System zur Wiedergabe von Informationen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee